Advisors Preferred’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-99
Closed -$16K 175
2020
Q3
$16K Sell
99
-100
-50% -$16.3K ﹤0.01% 132
2020
Q2
$34K Buy
+199
New +$31.2K 0.01% 122
2019
Q2
Sell
-312
Closed -$47K 237
2019
Q1
$47K Buy
+312
New +$44.9K 0.01% 153
2017
Q3
Sell
-95
Closed -$11K 234
2017
Q2
$11K Sell
95
-6
-6% -$645 0.01% 198
2017
Q1
$11 Buy
+101
New +$10.1K 0.01% 176
2015
Q3
Sell
-16,877
Closed -$2.09M 208
2015
Q2
$2.09M Sell
16,877
-2,227
-12% -$269K 1.17% 27
2015
Q1
$2.26M Sell
19,104
-4,890
-20% -$553K 1.2% 26
2014
Q4
$2.45M Buy
23,994
+22,738
+1,810% +$2.22M 1.15% 23
2014
Q3
$115K Sell
1,256
-575
-31% -$49.9K 0.07% 79
2014
Q2
$151K Buy
+1,831
New +$140K 0.08% 93
2014
Q1
Sell
-826
Closed -$57K 365
2013
Q4
$57K Buy
+826
New +$54.2K 0.03% 175

Other funds holding FBT

Advisors Preferred's FBT Position: Q4 2020 in Review

Advisors Preferred sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2020, closing a stake of 99 shares — an estimated $16K sold.

Advisors Preferred first reported a position in FBT in Q4 2013 and held it in 11 quarters. The position peaked at $2.45M in Q4 2014. 236 funds tracked by Wall St. Rank hold FBT as of Q4 2020.

  • Advisors Preferred reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2020 after selling out during the quarter.
  • Advisors Preferred sold 99 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2020, an estimated $16K.
  • Advisors Preferred first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 11 quarters.
  • Advisors Preferred's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.45M in Q4 2014.
  • 236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2020.

Based on Advisors Preferred's 13F filing for Q4 2020, filed 3 Feb 2021.